The book presents new and novel perceptions about ailments alleviating the effects of several mushroom species. Also, the book highlights the curative role of medicinal mushrooms on some peripheral and central diseases. Various chapters in the book (primarily reviews) have been dedicated to providing the therapeutic efficacy of mushrooms against respiratory illnesses, gut microbiota, COVID-19, dementia, epilepsy, mental ailments, cancers, cardiovascular, kidney-related diseases, and other common pathologies. Thus, medicinal mushrooms are current and future consumable healthcare products that usually exhibit nourishing properties and possess prophylactic and therapeutic values with minimal adverse effects and contraindications. The book focuses on Sustainable Development Goal (SDG 3) to promote healthy lives and well-being for all.
Medical, pharmacy, nursing, and CAM (complementary and alternative medicine) students, practitioners, scholars, researchers, other healthcare professionals, and general readers are this book’s potential audience. The book can be adopted as a textbook for undergraduate and graduate courses so that the therapeutic potential of mushrooms can reach a wider audience. This book strives to create a new resource for the future use of medicinal mushrooms in various disorders.
Chapter 1. Mushrooms as Promising Therapeutic Resources: Review and
Future Perspectives.
Chapter
2. Medicinal Mushrooms for Respiratory Health.-
Chapter
3. Therapeutic and Prophylactic Potential of Medicinal Mushrooms in
COVID-19.
Chapter
4. Influences of Edible Mushrooms on Dynamic and Diversity
of Gut Microbiota.
Chapter
5. Mushrooms From Traditional Remedies to the
Modern Therapeutics.
Chapter
6. Biopharmaceutical Potential of
Ophiocordyceps sinensis for Human Health.
Chapter
7. Anticancer Potential of
Ganoderma lucidum and ts Relevant Modes of Action.
Chapter
8. Cognitive
Enhancing Effects of Medicinal Mushrooms: A Potential Neuroprotective
Implication in Dementias.
Chapter
9. Potential of Medicinal Mushrooms in
Human Health and Welfare: An Overview.
Chapter
10. Mycotherapeutics Reduce
Nephrotoxicity and Renal Diseases.
Chapter
11. Proteomic Research on the
Therapeutic Properties of Medicinal Mushrooms.
Chapter
12. Cordyceps
militaris (L.): Medicinal aspects in terms of ethnobotanical and
pharmacological perspectives.
Chapter
13. Mycotherapeutics Affecting
Dopaminergic Neurotransmission to Exert Neuroprotection.
Chapter
14.
Biological Activities of Some Edible Mushrooms.
Chapter
15. Nephroprotective
Effects of Four Ganoderma Species.
Chapter
16. Mechanisms Involved in
EdibleMushrooms'Health Beneficial Effects.
Chapter
17. Mycotherapy
(Medicinal Mushrooms) as a Potential Treatment for Epilepsy.
Chapter
18.
Natural vs. Synthetic Psilocybin: The Same or Completely Different?.
Chapter
19. Preventative and Curative Properties of Reishi and Maitake Mushrooms in
Cancer.
Dr. Dinesh Chandra Agrawal, Ph.D., is a professor in the Department of Applied Chemistry, at Chaoyang University of Technology (CYUT), Taiwan. He has more than 40 years of research experience in the biotechnology of diverse species, including medicinal plants and mushrooms, and has more than 200 publications, including 8 books (6 by Springer Nature). Professor Agrawal has been bestowed several prestigious awards and fellowships, including the Alexander von Humboldt Fellowship (Germany), DBT Overseas Associateship to USDA, Mississippi State (USA), British Council Scholar (UK), European Research Fellow (UK), and INSA Visiting Scientist (India). Currently, Professor Agrawal is serving as Associate Editor-in-Chief of the International Journal of Applied Science and Engineering (Scopus)
Dr. Muralikrishnan Dhanasekaran, Ph.D., is a Professor in the Department of Drug Discovery and Development at Harrison School of Pharmacy, Auburn University, USA. He has more than 90 peer-reviewed international publications and several book chapters and is a reviewer in various peer-reviewed journals. Dr. Dhanasekarans lab and research interests are in preclinical research and drug development in neuropharmacology. His current research involves elucidating the neuroprotective and neurotoxic effects of botanicals and synthetic compounds; discovering and developing drugs/compounds targeting Alzheimers and Parkinsons diseases.
Lisainfo e-raamatute kohta